US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist

11.840
-0.680-5.43%

Close May 17 16:00 ET

12.300
+0.460+3.89%

Post 19:58 ET

616.68MMarket Cap-6541P/E (TTM)

EyePoint Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-85.16%-31.17M

102.88%1.88M

-83.58%-23.11M

-15.74%-15.2M

398.19%57.02M

16.48%-16.84M

-29.76%-65.01M

24.48%-12.59M

-68.69%-13.14M

-81.38%-19.12M

Net income from continuing operations

-38.37%-29.28M

30.77%-70.8M

67.55%-14.1M

31.53%-12.61M

-18.11%-22.92M

-0.90%-21.16M

-75.04%-102.25M

-123.61%-43.45M

-10.33%-18.42M

-93.87%-19.41M

Operating gains losses

----

-13.60%1.35M

--0

----

175.50%1.56M

--0

Depreciation and amortization

188.57%303K

-81.03%464K

-66.57%112K

-83.83%115K

-81.25%132K

-84.91%105K

-11.73%2.45M

-52.01%335K

1.43%711K

2.77%704K

Deferred tax

----

--83K

----

--0

----

Other non cash items

-135.66%-575K

-53.41%-856K

-53.53%-522K

81.78%-39K

55.26%-51K

-321.82%-244K

-188.85%-558K

-304.82%-340K

-232.10%-214K

-174.51%-114K

Change In working capital

-1,109.45%-14.31M

2,047.80%58.88M

-352.53%-12.27M

-496.54%-6.3M

1,809.78%76.03M

128.22%1.42M

-73.84%-3.02M

322.32%4.86M

-71.51%1.59M

-815.02%-4.45M

-Change in receivables

-186.37%-4.26M

642.15%14.43M

-104.28%-269K

2,820.65%10.75M

84.64%-979K

267.93%4.93M

74.89%-2.66M

205.00%6.28M

-72.14%368K

-75.76%-6.37M

-Change in inventory

70.38%-351K

-104.34%-1.55M

179.41%671K

-13.72%-315K

-982.93%-724K

-523.21%-1.19M

-156.42%-760K

-245.69%-845K

-134.20%-277K

-60.00%82K

-Change in payables and accrued expense

36.92%-1.43M

26.79%1.52M

250.72%728K

-263.13%-2.89M

194.84%5.95M

-7.59%-2.27M

-85.87%1.2M

-114.02%-483K

-51.82%1.77M

-36.01%2.02M

-Change in other working capital

-13,243.55%-8.27M

5,667.46%44.48M

-14,468.48%-13.4M

-4,951.46%-13.84M

41,597.11%71.79M

76.15%-62K

16.68%-799K

60.17%-92K

-17.60%-274K

20.28%-173K

Cash from discontinued investing activities

Operating cash flow

-85.16%-31.17M

102.88%1.88M

-83.58%-23.11M

-15.74%-15.2M

398.19%57.02M

16.48%-16.84M

-29.76%-65.01M

24.48%-12.59M

-68.69%-13.14M

-81.38%-19.12M

Investing cash flow

Cash flow from continuing investing activities

-35.16%20.81M

80.80%-3.32M

-243.23%-47.15M

-127.42%-1.72M

112,325.00%13.47M

156.85%32.09M

47.87%-17.27M

199.85%32.92M

4,887.79%6.27M

52.00%-12K

Net PPE purchase and sale

-146.69%-1.19M

-62.00%-3.48M

-50.94%-883K

-43.57%-1.72M

-81.65%-396K

-224.83%-484K

-1,278.21%-2.15M

---585K

-814.50%-1.2M

-772.00%-218K

Net investment purchase and sale

-32.45%22M

101.11%168K

-238.10%-46.27M

--0

6,629.61%13.86M

157.86%32.57M

54.15%-15.12M

201.63%33.5M

--7.47M

--206K

Cash from discontinued investing activities

Investing cash flow

-35.16%20.81M

80.80%-3.32M

-243.23%-47.15M

-127.42%-1.72M

112,325.00%13.47M

156.85%32.09M

47.87%-17.27M

199.85%32.92M

4,887.79%6.27M

52.00%-12K

Financing cash flow

Cash flow from continuing financing activities

102.25%115K

27,211.59%187.07M

376,798.28%218.49M

11,163.04%10.36M

-13,181.88%-36.66M

-1,042.63%-5.12M

-100.32%-690K

-100.05%-58K

4,700.00%92K

27.56%-276K

Net issuance payments of debt

--0

-2,026.34%-40.51M

--0

-103,761.76%-35.31M

-335.52%-5.2M

1,540.41%2.1M

22.73%-34K

18.18%-36K

15.00%-34K

Net common stock issuance

----

--226.17M

--216.2M

----

--0

----

Proceeds from stock option exercised by employees

1,738.71%4.56M

754.94%3.38M

--2.32M

421.43%803K

--5K

2.90%248K

5.90%395K

--0

52.48%154K

--0

Net other financing activities

-2,530.18%-4.45M

38.21%-1.97M

-50.00%-36K

-1,496.15%-415K

-457.85%-1.35M

94.16%-169K

-2,025.33%-3.19M

-380.00%-24K

-100.36%-26K

28.82%-242K

Cash from discontinued financing activities

Financing cash flow

102.25%115K

27,211.59%187.07M

376,798.28%218.49M

11,163.04%10.36M

-13,181.88%-36.66M

-1,042.63%-5.12M

-100.32%-690K

-100.05%-58K

4,700.00%92K

27.56%-276K

Net cash flow

Beginning cash position

193.80%281.41M

-46.41%95.78M

76.38%133.19M

69.83%139.75M

4.15%105.92M

-46.41%95.78M

296.69%178.74M

-37.00%75.51M

-35.60%82.28M

-26.70%101.7M

Current changes in cash

-201.16%-10.25M

323.76%185.63M

631.23%148.23M

3.10%-6.56M

274.29%33.83M

113.15%10.13M

-162.06%-82.96M

-65.57%20.27M

14.49%-6.77M

-77.29%-19.41M

End cash Position

156.02%271.16M

193.80%281.41M

76.38%133.19M

69.83%139.75M

4.15%105.92M

-46.41%95.78M

-37.00%75.51M

-35.60%82.28M

Free cash flow

-86.88%-32.37M

97.61%-1.61M

-82.13%-23.99M

-18.07%-16.92M

392.78%56.63M

14.71%-17.32M

-33.63%-67.16M

20.97%-13.17M

-81.03%-14.33M

-83.01%-19.34M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-85.16%-31.17M	102.88%1.88M	-83.58%-23.11M	-15.74%-15.2M	398.19%57.02M	16.48%-16.84M	-29.76%-65.01M	24.48%-12.59M	-68.69%-13.14M	-81.38%-19.12M
Net income from continuing operations	-38.37%-29.28M	30.77%-70.8M	67.55%-14.1M	31.53%-12.61M	-18.11%-22.92M	-0.90%-21.16M	-75.04%-102.25M	-123.61%-43.45M	-10.33%-18.42M	-93.87%-19.41M
Operating gains losses	----	-13.60%1.35M	--0	--0	----	----	175.50%1.56M	--0	--0	--0
Depreciation and amortization	188.57%303K	-81.03%464K	-66.57%112K	-83.83%115K	-81.25%132K	-84.91%105K	-11.73%2.45M	-52.01%335K	1.43%711K	2.77%704K
Deferred tax	----	--83K	----	----	----	----	--0	----	----	----
Other non cash items	-135.66%-575K	-53.41%-856K	-53.53%-522K	81.78%-39K	55.26%-51K	-321.82%-244K	-188.85%-558K	-304.82%-340K	-232.10%-214K	-174.51%-114K
Change In working capital	-1,109.45%-14.31M	2,047.80%58.88M	-352.53%-12.27M	-496.54%-6.3M	1,809.78%76.03M	128.22%1.42M	-73.84%-3.02M	322.32%4.86M	-71.51%1.59M	-815.02%-4.45M
-Change in receivables	-186.37%-4.26M	642.15%14.43M	-104.28%-269K	2,820.65%10.75M	84.64%-979K	267.93%4.93M	74.89%-2.66M	205.00%6.28M	-72.14%368K	-75.76%-6.37M
-Change in inventory	70.38%-351K	-104.34%-1.55M	179.41%671K	-13.72%-315K	-982.93%-724K	-523.21%-1.19M	-156.42%-760K	-245.69%-845K	-134.20%-277K	-60.00%82K
-Change in payables and accrued expense	36.92%-1.43M	26.79%1.52M	250.72%728K	-263.13%-2.89M	194.84%5.95M	-7.59%-2.27M	-85.87%1.2M	-114.02%-483K	-51.82%1.77M	-36.01%2.02M
-Change in other working capital	-13,243.55%-8.27M	5,667.46%44.48M	-14,468.48%-13.4M	-4,951.46%-13.84M	41,597.11%71.79M	76.15%-62K	16.68%-799K	60.17%-92K	-17.60%-274K	20.28%-173K
Cash from discontinued investing activities
Operating cash flow	-85.16%-31.17M	102.88%1.88M	-83.58%-23.11M	-15.74%-15.2M	398.19%57.02M	16.48%-16.84M	-29.76%-65.01M	24.48%-12.59M	-68.69%-13.14M	-81.38%-19.12M
Investing cash flow
Cash flow from continuing investing activities	-35.16%20.81M	80.80%-3.32M	-243.23%-47.15M	-127.42%-1.72M	112,325.00%13.47M	156.85%32.09M	47.87%-17.27M	199.85%32.92M	4,887.79%6.27M	52.00%-12K
Net PPE purchase and sale	-146.69%-1.19M	-62.00%-3.48M	-50.94%-883K	-43.57%-1.72M	-81.65%-396K	-224.83%-484K	-1,278.21%-2.15M	---585K	-814.50%-1.2M	-772.00%-218K
Net investment purchase and sale	-32.45%22M	101.11%168K	-238.10%-46.27M	--0	6,629.61%13.86M	157.86%32.57M	54.15%-15.12M	201.63%33.5M	--7.47M	--206K
Cash from discontinued investing activities
Investing cash flow	-35.16%20.81M	80.80%-3.32M	-243.23%-47.15M	-127.42%-1.72M	112,325.00%13.47M	156.85%32.09M	47.87%-17.27M	199.85%32.92M	4,887.79%6.27M	52.00%-12K
Financing cash flow
Cash flow from continuing financing activities	102.25%115K	27,211.59%187.07M	376,798.28%218.49M	11,163.04%10.36M	-13,181.88%-36.66M	-1,042.63%-5.12M	-100.32%-690K	-100.05%-58K	4,700.00%92K	27.56%-276K
Net issuance payments of debt	--0	-2,026.34%-40.51M	--0	--0	-103,761.76%-35.31M	-335.52%-5.2M	1,540.41%2.1M	22.73%-34K	18.18%-36K	15.00%-34K
Net common stock issuance	----	--226.17M	--216.2M	----	----	----	--0	--0	----	----
Proceeds from stock option exercised by employees	1,738.71%4.56M	754.94%3.38M	--2.32M	421.43%803K	--5K	2.90%248K	5.90%395K	--0	52.48%154K	--0
Net other financing activities	-2,530.18%-4.45M	38.21%-1.97M	-50.00%-36K	-1,496.15%-415K	-457.85%-1.35M	94.16%-169K	-2,025.33%-3.19M	-380.00%-24K	-100.36%-26K	28.82%-242K
Cash from discontinued financing activities
Financing cash flow	102.25%115K	27,211.59%187.07M	376,798.28%218.49M	11,163.04%10.36M	-13,181.88%-36.66M	-1,042.63%-5.12M	-100.32%-690K	-100.05%-58K	4,700.00%92K	27.56%-276K
Net cash flow
Beginning cash position	193.80%281.41M	-46.41%95.78M	76.38%133.19M	69.83%139.75M	4.15%105.92M	-46.41%95.78M	296.69%178.74M	-37.00%75.51M	-35.60%82.28M	-26.70%101.7M
Current changes in cash	-201.16%-10.25M	323.76%185.63M	631.23%148.23M	3.10%-6.56M	274.29%33.83M	113.15%10.13M	-162.06%-82.96M	-65.57%20.27M	14.49%-6.77M	-77.29%-19.41M
End cash Position	156.02%271.16M	193.80%281.41M	193.80%281.41M	76.38%133.19M	69.83%139.75M	4.15%105.92M	-46.41%95.78M	-46.41%95.78M	-37.00%75.51M	-35.60%82.28M
Free cash flow	-86.88%-32.37M	97.61%-1.61M	-82.13%-23.99M	-18.07%-16.92M	392.78%56.63M	14.71%-17.32M	-33.63%-67.16M	20.97%-13.17M	-81.03%-14.33M	-83.01%-19.34M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall